BEUDAMED
    FDA Adverse Event Death Summary report: N

    THORAFLEX HYBRID

    MDR report key: 22859478 · Received August 21, 2025

    Report

    Report Number
    9612515-2025-00070
    Event Type
    Death
    Date Received
    August 21, 2025
    Date of Event
    April 7, 2025
    Report Date
    October 16, 2025
    Manufacturer
    VASCUTEK LTD.
    Product Code
    QSK
    UDI-DI
    05037881026725
    PMA / PMN Number
    P210006
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    MA, US
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    MANUFACTURER NARRATIVE: CLINICAL CODE: E. 1942 - ISCHEMIA - EVENT OF ISCHAEMIC RIGHT FOOT REPORTED FORM THE EXTEND STUDY (B)(6). ON POST-OPERATIVE DAY 40 ((B)(6) 2025), FURTHER DETAILS STATING "REDUCED BLOOD SUPPLY TO THE FOOT". IMPACT CODE: F. 1802- DEATH - DESPITE INTENSIVE CARE AND SUPPORTIVE MEASURES , THE PATIENT'S CONDITION CONTINUED TO DETERIORATE . CULMINATING IN DEATH ON (B)(6) 2025. DEVICE PROBLEM CODE :A. 3190 - INSUFFICIENT INFORMATION - NO DEVICE FAILURE /DEFICIENCY HAS BEEN REPORTED. COMPONENT CODE: G. 4755 - PART/COMPONENT/SUB-ASSEMBLY TERM NOT APPLICABLE. TYPE OF INVESTIGATION: B. 4110 - TREND ANALYSIS: -NO HISTORICAL DATA IS AVAILABLE TO PERFORM A SIMILAR EVENT REVIEW AS THIS IS THE FIRST EVENT OF ISCHEMIA REPORTED IN THORAFLEX HYBRID DEVICES IN 4 YEARS. 4111 - COMMUNICATION INTERVIEW: ADDITIONAL INFORMATION TO AID THIS INVESTIGATION WAS REQUESTED ON WAS REQUESTED ON 11TH AUG, 28TH AUG , 09TH SEP 25 AND 08 OCT 25, TO DATE ANSWERS TO QUESTIONS HAVE NOT BEEN RECEIVED. 3331 - ANALYSIS OF PRODUCTION RECORDS: FULL BATCH REVIEW PERFORMED FROM BASE FABRIC TO FINISHED PRODUCT FOR DEVICE ID-25584139 WHICH CONFIRMED THE BATCH WAS MANUFACTURED TO SPECIFICATION. 4117 - DEVICE NOT RETURNED: DEVICE REMAINS IMPLANTED. INVESTIGATION FINDINGS: C. 213 - NO DEVICE PROBLEM FOUND - FULL BATCH REVIEW WAS PERFORMED WHICH CONFIRMED THE DEVICE WAS MANUFACTURED TO SPECIFICATION. INVESTIGATION CONCLUSION: D. 4315 - CAUSE NOT ESTABLISHED - AS NO DEVICE FAILURE / DEFICIENCY WAS REPORTED, FULL REVIEW OF RETAINED MANUFACTURING RECORDS SHOWED THE DEVICE WAS MANUFACTURED TO SPECIFICATION WITH NO ISSUES FOUND, NO ISSUES, NO SCANS ARE AVAILABLE FOR REVIEW AND WE HAVE HAD NO REPLY TO THE QUESTIONS ASKED , NO CAUSAL LINK BETWEEN THE EVENT AND THE DEVICE COULD BE IDENTIFIED. ADDITIONAL INFORMATION SECTION B2 UPDATED TO DEATH. SECTION B3 ADDED DATE OF DEATH. SECTION B5 ADDED PATIENT PASSED AWAY. SECTION H11 - TYPE OF INVESTIGATION 4110 TREND ANALYSIS WAS UPDATED FROM OCCLUSION / THROMBOSIS IN INITIAL REPORT TO MEDICAL EVENT OTHER IN THE FINAL REPORT AFTER A FAILURE MODE CATEGORY UPDATE.

    Additional Manufacturer Narrative · 0

    MANUFACTURER NARRATIVE: CLINICAL CODE: 1942 - ISCHEMIA - EVENT OF ISCHAEMIC RIGHT FOOT REPORTED FORM THE EXTEND STUDY (B)(6). ON POST-OPERATIVE DAY 40 ((B)(6) 2025), FURTHER DETAILS STATING, "REDUCED BLOOD SUPPLY TO THE FOOT". IMPACT CODE: 4648- INSUFFICIENT INFORMATION - PATIENT OUTCOME IS UNKNOWN AT THE TIME OF REPORTING. DEVICE PROBLEM CODE: 3190 - INSUFFICIENT INFORMATION - NO DEVICE FAILURE /DEFICIENCY HAS BEEN REPORTED. COMPONENT CODE: 4755 - PART/COMPONENT/SUB-ASSEMBLY TERM NOT APPLICABLE. TYPE OF INVESTIGATION: 4110 - TREND ANALYSIS: -THORAFLEX HYBRID SALES (B)(6) 2021 - (B)(6) 2025 V THORAFLEX HYBRID > OCCLUSION/THROMBOSIS > LEG (B)(6) 2021 - (B)(6) 2025 HAD AN OCCURRENCE RATE OF <(B)(4) NO TREND REQUIRING ACTION HAS BEEN IDENTIFIED. 4111 - COMMUNICATION INTERVIEW: ADDITIONAL INFORMATION TO AID THIS INVESTIGATION HAS BEEN REQUESTED. 3331 - ANALYSIS OF PRODUCTION RECORDS: FULL BATCH REVIEW PERFORMED FROM BASE FABRIC TO FINISHED PRODUCT FOR DEVICE ID-(B)(6) WHICH CONFIRMED THE BATCH WAS MANUFACTURED TO SPECIFICATION WITH NO ISSUES FOUND. 4117 - DEVICE NOT RETURNED: DEVICE REMAINS IMPLANTED. INVESTIGATION FINDINGS: 3233 - RESULTS PENDING COMPLETION OF INVESTIGATION. INVESTIGATION CONCLUSION: 11 - CONCLUSION NOT YET AVAILABLE AS INVESTIGATION IS ONGOING.

    Description of Event or Problem · 0

    EVENT OF ISCHAEMIC RIGHT FOOT REPORTED FORM THE EXTEND STUDY (B)(6). (B)(6), A CAUCASIAN MALE AGED 77 AT TIME OF CONSENT (TAKEN (B)(6) 2025), UNDERWENT AN ELECTIVE OPEN SURGICAL REPAIR OF THE AORTA WITH A THORAFLEX HYBRID, ON POST-OPERATIVE DAY 40 ((B)(6) 2025), (B)(6) EXPERIENCED AN ADVERSE EVENT OF ISCHAEMIC RIGHT FOOT, FURTHER DETAILS STATING "REDUCED BLOOD SUPPLY TO THE FOOT". TREATMENT OF EVENT INCLUDED MEDICATION (MEDICATION UNCONFIRMED). IT IS UNKNOWN AT TIME OF INITIAL REPORTING IF THE EVENT WAS ONGOING, HOWEVER ADDITIONAL INFORMATION WAS RECEIVED TO SAY THE PATIENT PASSED AWAY ON (B)(6) 2025. INVESTIGATOR CONSIDERED THE EVENT UNANTICIPATED AND SEVERE IN NATURE. EVENT WAS CONSIDERED RELATED TO PROCEDURE, POSSIBLY RELATED TO DEVICE, NOT RELATED TO A DEVICE DEFICIENCY/FAILURE, AND POSSIBLY RELATED TO A PRE-EXISTING CONDITION. THIS REPORT IS BEING SUBMITTED AS FOLLOW UP #1 FOR MANUFACTURING REPORT NUMBER 9612515-2025-00070 TO PROVIDE EVENT CLOSURE INFORMATION FOR (B)(4).

    Description of Event or Problem · 0

    EVENT OF ISCHAEMIC RIGHT FOOT REPORTED FORM THE EXTEND STUDY (B)(6). SUBJECT (B)(6), A CAUCASIAN MALE AGED 77 AT TIME OF CONSENT (TAKEN (B)(6) 2025), UNDERWENT AN ELECTIVE OPEN SURGICAL REPAIR OF THE AORTA WITH A THORAFLEX HYBRID, ON POST-OPERATIVE DAY 40 ((B)(6) 2025), SUBJECT (B)(6) EXPERIENCED AN ADVERSE EVENT OF ISCHAEMIC RIGHT FOOT, FURTHER DETAILS STATING, "REDUCED BLOOD SUPPLY TO THE FOOT". TREATMENT OF EVENT INCLUDED MEDICATION (MEDICATION UNCONFIRMED). IT IS UNKNOWN AT TIME OF REPORTING IF THE EVENT IS ONGOING. INVESTIGATOR CONSIDERED THE EVENT UNANTICIPATED AND SEVERE IN NATURE. EVENT WAS CONSIDERED RELATED TO PROCEDURE, POSSIBLY RELATED TO DEVICE, NOT RELATED TO A DEVICE DEFICIENCY/FAILURE, AND POSSIBLY RELATED TO A PRE-EXISTING CONDITION.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2053636 THORAFLEX HYBRID THORAFLEX HYBRID PLEXUS QSK VASCUTEK LTD. N/A 25584139 05037881026725

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Male Death| O